Navigation Links
Indeterminate breast lesions found in high-risk patients should be evaluated aggressively to exclude malignancy
Date:5/3/2010

Short-term follow-up is often used to evaluate indeterminate breast lesions found on breast magnetic resonance imaging (MRI). However, researchers have found that indeterminate lesions (found in women with a high risk of breast cancer) should be evaluated sooner to exclude a possible malignancy, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Breast lesions that cannot be definitively classified as suspicious for malignancy or benign are considered indeterminate. "A short-term follow-up MRI, ultrasound, and/or mammographic investigation is usually recommended for indeterminate lesions found in high-risk women," said Martin Korzeniowski, MD, lead author of the study. "However, that may not be soon enough," said Korzeniowski. High-risk women include those who have breast cancer, a history of breast cancer, or a genetic predisposition.

The study, performed at McMaster University in Hamilton, Canada, included 59 lesions in 55 patients that were identified on breast MRI as indeterminate. "Of those indeterminate lesions, a significant number (22 percent) were proven positive for malignancy on follow-up and subsequent biopsy," he said.

"In our study, the cancer yield was substantial for indeterminate lesions identified on initial contrast-enhanced breast MRI which suggests that those lesions should be evaluated more aggressively to exclude malignancy and increase one's chances for survival," said Korzeniowski.


'/>"/>

Contact: Heather Curry
hcurry@acr-arrs.org
703-390-9822
American College of Radiology / American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment
2. Smoking Ups Risk of Second Breast Cancer
3. Summer Brings Increased Demand For Breast and Body Enhancement
4. Largest Internet Supplier of Eternity Rings Pledges 10% of their Profits to the National Breast Cancer Foundation
5. Breakthrough in Predicting Invasive Breast Cancer
6. Comparison of available breast cancer risk assessment tools shows room for improvement
7. Breakthrough method predicts risk of invasive breast cancer
8. Cell study finds receptor can fight tamoxifen-resistant breast cancer cells
9. Breast Cancer Risks Not Same for Hispanic Women
10. Breast cancer risk factors differ among races
11. Global Summit on International Breast Health Targets Breast Health Improvements in Developing Countries, June 9-11, 2010, in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... 2017 , ... New patients from Charleston, SC, are now welcome to receive ... Pleasant, SC, with or without a referral. A full mouth reconstruction can transform the ... in Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw ...
(Date:5/23/2017)... ... May 23, 2017 , ... Patients in need of a ... practice to schedule an appointment, with or without a referral. Dr. Cotey is a ... to pediatric patients as a healthy alternative to a tooth extraction. , When a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... 22, 2017 , ... OSF Ventures, the corporate investment arm ... early stage company in San Francisco that has developed software to individualize treatment ... Fund acted as the lead investor in the round. , Medicine is ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology: